Literature DB >> 21561853

Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent.

Carol P Curtiss1.   

Abstract

Entities:  

Year:  2011        PMID： 21561853     DOI： 10.1136/ebn1150

Source DB:  PubMed          Journal:  Evid Based Nurs        ISSN： 1367-6539


× No keyword cloud information.
  3 in total

1.  Letter to the editor: pharmacokinetics of non-intravenous formulations of fentanyl.

Authors:  Donald R Taylor; Allen W Burton; Nashat Y Gabrail; Didier Mayeur; Philippe Poulain; Alain Serrie; Luis M Torres
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

Review 2.  Pharmacokinetics of non-intravenous formulations of fentanyl.

Authors:  Jörn Lötsch; Carmen Walter; Michael J Parnham; Bruno G Oertel; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

3.  Efficacy and Safety of Fentanyl Compared With Morphine among Adult Patients with Cancer: A Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Sébastien Manirakiza; Prudence Bizimana
Journal:  East Afr Health Res J       Date:  2020-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.